- Home
- BOX vs KRYS Comparison
BOX vs KRYS Comparison
Compare BOX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOX
- KRYS
- Stock Information
- Founded
- BOX 2005
- KRYS 2015
- Country
- BOX United States
- KRYS United States
- Employees
- BOX N/A
- KRYS N/A
- Industry
- BOX Computer Software: Prepackaged Software
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOX Technology
- KRYS Health Care
- Exchange
- BOX Nasdaq
- KRYS Nasdaq
- Market Cap
- BOX 4.6B
- KRYS 4.6B
- IPO Year
- BOX 2015
- KRYS 2017
- Fundamental
- Price
- BOX $33.46
- KRYS $187.96
- Analyst Decision
- BOX Strong Buy
- KRYS Strong Buy
- Analyst Count
- BOX 10
- KRYS 7
- Target Price
- BOX $34.60
- KRYS $210.00
- AVG Volume (30 Days)
- BOX 1.2M
- KRYS 245.3K
- Earning Date
- BOX 03-04-2025
- KRYS 02-19-2025
- Dividend Yield
- BOX N/A
- KRYS N/A
- EPS Growth
- BOX 299.10
- KRYS 669.23
- EPS
- BOX 0.80
- KRYS 3.00
- Revenue
- BOX $1,073,488,000.00
- KRYS $290,515,000.00
- Revenue This Year
- BOX $6.10
- KRYS $483.09
- Revenue Next Year
- BOX $6.45
- KRYS $57.70
- P/E Ratio
- BOX $41.63
- KRYS $62.62
- Revenue Growth
- BOX 4.09
- KRYS 473.02
- 52 Week Low
- BOX $24.63
- KRYS $109.57
- 52 Week High
- BOX $35.74
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- BOX 46.36
- KRYS 73.39
- Support Level
- BOX $34.15
- KRYS $148.00
- Resistance Level
- BOX $35.42
- KRYS $190.00
- Average True Range (ATR)
- BOX 0.62
- KRYS 7.31
- MACD
- BOX -0.07
- KRYS 3.66
- Stochastic Oscillator
- BOX 20.38
- KRYS 93.87
About BOX Box Inc.
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file-sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature to enhance workflow management and collaboration.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.